We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$328M
AUM Growth
-$9.02M
Cap. Flow
-$9.59M
Cap. Flow %
-2.92%
Top 10 Hldgs %
36.34%
Holding
213
New
5
Increased
48
Reduced
109
Closed
12

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$968K
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$747K
3
NVO
Novo Nordisk
NVO
+$656K
4
ASML icon
ASML
ASML
+$540K
5
AMAT icon
Applied Materials
AMAT
+$401K

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.56M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.24M
3
CRL icon
Charles River Laboratories
CRL
+$964K
4
AAPL icon
Apple
AAPL
+$951K
5
CVS icon
CVS Health
CVS
+$647K

Sector Composition

Rank Sector Weight
1 Technology 16.85%
2 Healthcare 16.12%
3 Financials 14.31%
4 Industrials 8.77%
5 Communication Services 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABEV icon
201
Ambev
ABEV
$47.9B
$80.3K 0.02%
34,480
– –
ALB icon
202
Albemarle
ALB
$13.8B
– –
-2,883
Closed -$248K
CRL icon
203
Charles River Laboratories
CRL
$11.2B
– –
-5,223
Closed -$964K
CVS icon
204
CVS Health
CVS
$134B
– –
-14,407
Closed -$647K
DELL icon
205
Dell
DELL
$262B
– –
-1,877
Closed -$216K
FSLR icon
206
First Solar
FSLR
$22.8B
– –
-1,158
Closed -$204K
ILMN icon
207
Illumina
ILMN
$30.1B
– –
-2,670
Closed -$357K
MORN icon
208
Morningstar
MORN
$7.19B
– –
-610
Closed -$205K
NBIX icon
209
Neurocrine Biosciences
NBIX
$16.9B
– –
-1,492
Closed -$204K
OGN icon
210
Organon & Co
OGN
$3.56B
– –
-13,826
Closed -$206K
TROW icon
211
T. Rowe Price
TROW
$24.2B
– –
-1,875
Closed -$212K
UFPI icon
212
UFP Industries
UFPI
$4.92B
– –
-1,788
Closed -$201K
USLM icon
213
United States Lime & Minerals
USLM
$3.17B
– –
-2,300
Closed -$305K
5 6 7 8
9

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Roberts, Glore & Co held 213 positions worth $328M, down 2.7% from $337M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Roberts, Glore & Co's Q1 2025 filing shows 5 new, 48 increased, 109 reduced and 12 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 12,006 shares worth $981K. The largest sale was Berkshire Hathaway Class B, an estimated $1.56M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Roberts, Glore & Co's largest Q1 2025 buy was iShares MSCI EAFE ETF: 12,006 shares worth $981K.
  • Roberts, Glore & Co added most to Vanguard S&P 500 ETF in Q1 2025, an estimated $747K increase.
  • Roberts, Glore & Co's biggest Q1 2025 reduction was Berkshire Hathaway Class B, cutting an estimated $1.56M.
  • Roberts, Glore & Co fully exited Charles River Laboratories in Q1 2025, selling an estimated $964K.
  • Roberts, Glore & Co's ten largest holdings make up 36% of its $328M portfolio in Q1 2025.
  • Roberts, Glore & Co opened 5 new positions and closed 12 in Q1 2025.
  • Roberts, Glore & Co's portfolio value fell 2.7% quarter-over-quarter to $328M.

Based on Roberts, Glore & Co's 13F filing for Q1 2025, filed 9 May 2025.